Back
InflaRx NV 10K Form
Sell
49
IFRX
InflaRx NV
Last Price:
1.61
Seasonality Move:
-13.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IFRX News And Ratings
See the #1 stock for the next 7 days that we like better than IFRX
IFRX Financial Statistics
Sales & Book Value
| Annual Sales: | $68.3K |
|---|---|
| Cash Flow: | $-16.17M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.74 |
| Price / Book: | 0.94 |
Profitability
| EPS (TTM): | -0.78040 |
|---|---|
| Net Income (TTM): | $-44.7M |
| Gross Margin: | $-507.93K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
InflaRx NV Earnings Forecast
Key InflaRx NV Financial Ratios
- The Gross Profit Margin over the past 3 years for IFRX is -743.67%.
- The Selling, General & Administrative Expenses for IFRX have been equal to 25,554.89% of Gross Profit Margin.
- The Research & Development expenses have been 65,026.50% of Revenue.
- The Interest Expense is -0.08% of Operating Income.
- The Net Earning history of IFRX is -67,631.41% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 4 years.
InflaRx NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IFRX |
| CUSIP: | N44821 |
| Website: | inflarx.de |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 8.9 |
| Quick Ratio: | 7.44 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IFRX Technical Analysis vs Fundamental Analysis
Sell
49
InflaRx NV (IFRX)
is a Sell
Is InflaRx NV a Buy or a Sell?
-
InflaRx NV stock is rated a Sell
The current InflaRx NV [IFRX] share price is $1.63. The Score for IFRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.